MedTrace Logo

Efficacy of VRx MyBiotics Oral Lozenges

NCT05972330 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2024-02-12

No results posted yet for this study

Summary

This study will test the efficacy of Viome's VRx MyBiotics Oral Lozenges at improving the oral microbiome.

Conditions

  • Oral Microbiome Health

Interventions

DIETARY_SUPPLEMENT

VRx MyBiotics Oral Lozenges

VRx MyBiotics Oral Lozenges are composed of prebiotics, probiotics, and postbiotics.

Sponsors & Collaborators

  • Viome

    lead INDUSTRY

Principal Investigators

  • Momchilo Vuyisich · Viome

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-06-26
Primary Completion
2024-01-26
Completion
2024-01-26

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05972330 on ClinicalTrials.gov